Acción QPT QUEST PHARMATECH INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Quest PharmaTech Inc.

Acciones

QPT

CA74836M1068

Mercado cerrado - Toronto S.E.
Otros sitios de cotización
 19:25:29 03/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,02 CAD -33,33 % Gráfico intradía de Quest PharmaTech Inc. 0,00 % -63,64 %
23/01 Quest PharmaTech Inc. Recibe recomendaciones del Consejo de Supervisión de la Seguridad de los Datos para interrumpir el estudio clínico de fase III de oregovomab CI
2023 Quest PharmaTech Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 31 de octubre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Quest PharmaTech Brief: Says Quest has a 42.5% ownership interest in OncoQuest; Adds dividend income will be used by Quest for general corporate purposes
Quest PharmaTech Brief: Received a cash dividend payment from OncoQuest Inc. of approximately C$685,000
Quest Receives Cash Dividend Payment from OncoQuest
Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis
Quest PharmaTech Inc. - Oregovomab Phase III Clinical Study fails futility analysis, Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits
Quest PharmaTech Inc. Receives Recommendations from the Data Safety Monitoring Board to Discontinue Oregovomab Phase III Clinical Study
Quest PharmaTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023
Quest PharmaTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023
Quest PharmaTech Provides Corporate Update
Quest PharmaTech Announces Results from AGM
Quest PharmaTech Provided Product Development Update
Quest PharmaTech Provides Product Development Update
Quest PharmaTech Inc. Provides Product Development Update
Quest PharmaTech Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023
Quest PharmaTech Provides Corporate Update
Canadian Investment Regulatory Organization Trade Resumption - QPT
Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.
Canadian Investment Regulatory Organization Trading Halt - QPT
Quest PharmaTech Provides Corporate Update
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción QPT
  4. Noticias Quest PharmaTech Inc.
  5. Otros idiomas